Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs GE Vernova Inc (GEV) Price & Performance

Centene CorpTrade
GE Vernova IncTrade

Price performance (Past 24H)

Key statistics

Centene Corp vs GE Vernova Inc — how do they compare? Centene Corp trades at $66.06 (market cap $33.93B), while GE Vernova Inc trades at $1,078.5 (market cap $286.46B). The key difference: GE Vernova Inc is far larger — about 8.4× Centene Corp's market cap, and GE Vernova Inc pays a 0.19% dividend while Centene Corp pays none. Which is the better fit depends on your goals.

CNCGEV
Market Cap
$33.93B$286.46B
Sector
HealthTechnology
52-Week High
$68.72$1.17K
52-Week Low
$25.21$547.96
Enterprise Value
$26.56B$279.09B
Dividend Yield
0.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.

Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.

GE Vernova Inc

GE Vernova (GEV) trades at $1,042.60, down 4.49% today, amid mixed technical signals but strong fundamental momentum. The stock shows bullish moving averages and oversold RSI conditions, while recent earnings beats and a 23.81% net income margin highlight robust profitability. Analyst consensus remains strongly bullish with a $1,240 price target, supported by the company's $11 billion investment in grid reliability and nuclear energy expansion.

Outlook: GEV's leadership in AI power infrastructure and nuclear technology positions it for long-term growth, though high valuation multiples (P/E 31.15) and execution risks on capital investments warrant caution. Near-term catalysts include Q2 2026 earnings on July 22, 2026, and dividend payments in July.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About GE Vernova Inc

GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.

Read more on GEV